Chronic kidney disease after liver transplantation: Pretransplantation risk factors and predictors during follow-up

Transplantation

Volumn 95, Issue 9, 2013, Pages 1148-1153

  Giusto, Michela ^a   Berenguer, Marina ^b,c   Merkel, Carlo ^d   Aguilera, Victoria ^b,c   Rubin, Angel ^b,c   Ginanni Corradini, Stefano ^a   Mennini, Gianluca ^a   Rossi, Massimo ^a   Prieto, Martin ^b,c   Merli, Manuela ^a,e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITY OF PADOVA   (Italy)

^e II Gastroenterologia   (Italy)

Author keywords

Chronic kidney disease; Liver transplantation; MDRD; Prediction; Prognosis

Indexed keywords

CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHRONIC GRAFT REJECTION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIALYSIS; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCIDENCE; INFECTION; KIDNEY FUNCTION TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VALIDITY;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84877578690     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182884890     Document Type: Article

References (30)

1. Ojo AO, Held PJ, Pork FK, et al. Chronic renal failure after transplantation of non-renal organ. N Engl J Med 2003; 349: 9331.
2. Gonwa TA, Jennings L, Mai ML, et al. Estimation of glomerular filtration rate before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004; 10: 301.
3. Sharma P, Welch K, Eikstadt R, et al. Renal outcomes after liver transplantation in the Model for End-Stage Liver Disease era. Liver Transpl 2009; 15: 1142.
4. Puschett JB, Greenberg A, Holley J, et al. The spectrum of cyclosporine nephrotoxicity. Am J Nephrol 1990; 10: 296.
5. Wheatley T, Clark PM, Clark JD, et al. Long-term effects of cyclosporine on renal function in liver transplant recipients. Transplantation 1987; 43: 641.
6. Bennett WM, DeMattos A, Meyer MM, et al. Chronic cyclosporine nephropathy in renal transplantation. Transplant Proc 1996; 28: 2100.
7. Gonwa TA, Mai ML, Melton LB, et al. End-stage renal disease (ESRD) following orthotopic liver transplantation (OLTX) utilizing calcineurin-based immunotherapy: risk of development and treatment. Transplantation 2001; 72: 934.
8. Pawarode A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003; 9: 741.
9. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002; 35: 1179.
10. Burra P, Senzolo M, Masier A, et al. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. Dig Liver Dis 2009; 41: 350.
11. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124:91.
12. Sanchez EQ, Melton LB, Chinnakotla S, et al. Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up. Transplantation 2010; 89: 232.
13. Gonwa TA, McBride MA, Anderson K, et al. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the U.S.: where will MELD lead us? Am J Transplant 2006; 6: 2651.
14. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089.
15. Fisher NC, Nightingale PG, Gunson BK, et al. Chronic renal failure following liver transplantation. Transplantation 1998; 66:59.
16. Gayowski T, Singh N, Keyes L, et al. Late onset of renal failure after liver transplantation: role of posttransplant alcohol use. Transplantation 2000; 69: 383.
17. Campbell M, Kotlyar D, Bresinger C, et al. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl 2005; 11: 1048.
18. Bahirwani R, Campbell MS, Siropaides T, et al. Transplantation: impact of pretransplant renal insufficiency. Liver Transpl 2008; 14: 665.
19. Sanchez EQ, Gonwa TA, Levy MR, et al. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation 2004; 78: 1048.
20. Christensen E, Altman DG, Neuberger J, et al. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. Gastroenterology 1993; 105: 1865.
21. Merkel C, Bolognesi M, Berzigotti A, et al. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early goodresponders on haemodynamic criteria. J Hepatol 2010; 52:45.
22. Merkel C, Morabito A, Sacerdoti D, et al. Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates. Ital J Gastroenterol Hepatol 1998; 30: 276.
23. Angeli P, Gines P. Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice. J Hepatol 2012; 57: 1135.
24. Weber ML, Ibrahim HN, Lake JR. Renal dysfunction in liver transplant recipients: evaluation of the critical issues. Liver Transpl 2012; 18: 1290.
25. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate form serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461.
26. European Association for the Study of Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis and hepato-renal syndrome in cirrhosis. J Hepatol 2010; 53: 1177.
27. Bellomo R, Ronco C, Kellum JA, Acute Dialysis Quality Initiative Workgroup, et al. Acute renal failureVdefinition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: 204.
28. American Diabetes Association. Standard of medical care in diabetesV2009. Diabetes Care 2009; 32: S13.
29. Chobanian A, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560.
30. Banff Working Group, Demetris AJ, Adeyi O, Bellamy CO, et al. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 2006; 44: 489.